Extracellular Hsp90α (eHSp90α) is shown to mediate HDM-induced human bronchial epithelial dysfunction, suggesting that eHsp90α is a potential therapeutic target for the treatment of asthma [117]. The gene discussed is HSP90AA1; the disease is asthma.